Skip to main content

Advertisement

Log in

Carboprost Versus Oxytocin for Active Management of Third Stage of Labor: A Prospective Randomized Control Study

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Background and Objectives

Postpartum hemorrhage is the single largest and leading cause of maternal morbidity and mortality not only in developing countries but also in developed countries. The present study is an attempt to evaluate the scope of using prophylactic intramuscular carboprost tromethamine 125 μg in comparison with intramuscular oxytocin 10 units for the active management of third stage of labor.

Materials and Methods

Two hundred pregnant women at term with spontaneous onset of labor were included in the study and were randomly divided into 2 groups of 100 women each. Group A and group B were given injection oxytocin 10 units and injection carboprost tromethamine 125 μg intramuscularly, respectively, at the time of delivery of anterior shoulder. The main outcome measures with respect to third stage of labor were: duration, blood loss by volume, difference in hemoglobin, need for additional oxytocics and side effects.

Results

Subjects who received carboprost tromethamine 125 μg showed a significant reduction in duration of third stage of labor (p < 0.05) and blood loss (p < 0.01) when compared to the subjects who received oxytocin 10 units. Likelihood of occurrence of postpartum hemorrhage was reduced without significant side effects except for diarrhea. Additional need for other uterotonics after carboprost was significantly less compared to oxytocin.

Conclusion

Intramuscular carboprost 125 μg is a better cost-effective alternative as compared to 10 units intramuscular oxytocin in active management of third stage of labor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Carroli G, Cuesta C, Abalos E, et al. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008;22:999–1012.

    Article  PubMed  Google Scholar 

  2. Shah D, Divakar H, Meghal T. Combating post partum hemorrhage in India: moving forward. In: Christopher B-L, Louis GK, Andre BL, Mahantesh K, editors. A Textbook of postpartum hemorrhage, a comprehensive guide to evaluate, management and surgical intervention. 1st ed. UK: Sapiens Publishing; 2006. p. 434–41.

    Google Scholar 

  3. Park K. Preventive medicine in obstetrics, pediatrics and geriatrics. In: Park K, editor. Textbook of preventive and social medicine. 22nd ed. Banasridas Bhanot: Jabalpur; 2013. p. 516–9.

    Google Scholar 

  4. Bhattacharya P, Devi PK, Jain S, et al. Prophylactic use of 15(S) 15 methyl PGF2 alpha by intramuscular route for control of postpartum bleeding—a comparative trial with methylergometrine. Acta Obstet Gynecol Scand. 1988;145 Suppl:S13–15.

    Google Scholar 

  5. Begley CM, Gyte GM, Devane D, et al. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2011;11:CD007412.

    PubMed  Google Scholar 

  6. Leduc D, Senikas V, Lalonde AB, et al. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2009;31:980–93.

    Article  PubMed  Google Scholar 

  7. World Health Organization. WHO recommendations for the prevention of postpartum haemorrhage. Geneva: World Health Organisation, Department of Making Pregnancy Safer; 2007.

    Google Scholar 

  8. Chelmow D. Postpartum hemorrhage prevention: clinical evidence 2011: BMJ articles 2011 cited on 24/09/2013. www.pubmed.com.

  9. Hofmeyr GJ, Gulmezoglu AM. New development in the management of postpartum hemorrhage. In: Bonner J, editor. Recent advances in obstetrics and gynaecology. 21st ed. London: Churchill Livingstone; 2000. p. 56–66.

    Google Scholar 

  10. International Confederation of Midwives, International Federation of Obstetrics and Gynecology. Prevention and treatment of post-partum hemorrhage. New advances for low resource settings. Int J Gynecol Obstet. 2007;97:160–3.

    Article  Google Scholar 

  11. Gizzo S, Patrelli TS, Gangi SD, et al. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reprod Sci. 2013;20:1011–9.

    Article  PubMed  Google Scholar 

  12. Roach MK, Abramovici A, Tita AT. Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. Am J Perinatol. 2013;30(7):523–8.

    Article  PubMed  Google Scholar 

  13. Nordström L, Fogelstam K, Fridman G, et al. Routine oxytocin in the third stage of labor: a placebo controlled randomized trial. Br J Obstet Gynecol. 1997;104:781–6.

    Article  Google Scholar 

  14. Kamalajayaram V, Devi ED. Prophylactic PGF2α for control of postpartum bleeding a comparative study with methyl ergometrine. J Obstet Gynaecol India. 1994;44:393–7.

    Google Scholar 

  15. Anjaneyulu R, Devi PK, Jain S, et al. Prophylactic use of 15 (5) methyl PGF2α by IM route- A controlled clinical trial. Acta Obstet Gynecol Scand Suppl. 1988;145:9–11.

    Google Scholar 

  16. Vaid A, Dadhwal V, Mittal S, et al. A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor. Arch Gynecol Obstet. 2009;280:893–7.

    Article  CAS  PubMed  Google Scholar 

  17. Abdel-Aleem H, Abol Oyoun EM, Moustafa SA, et al. Carboprost trometamol in the management of the third stage of labor. Int J Gynaecol Obstet. 1993;42:247–50.

    Article  CAS  PubMed  Google Scholar 

  18. Bai J, Sun Q, Zhai H, et al. A comparison of oxytocin and carboprost in prevention of PPH in high risk patients in caesarean section. Exp Ther Med. 2014;7:46–50.

    CAS  PubMed  Google Scholar 

  19. Buttino L Jr, Garite TJ. The use of 15 methyl F2 alpha prostaglandin (Prostin 15 M) for the control of postpartum hemorrhage. Am J Perinatol. 1986;3:241–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. S. Sunil Kumar.

Ethics declarations

Conflict of interest

All authors of the study declare that there is no conflict of interest of any type.

Ethical Statement

Permission was obtained from the ethical committee of the institution.

Additional information

Dr. K. S. Sunil Kumar is Professor and Unit Head, and Dr. Sundar Shyam is Assistant Professor in Department of OBGYN at SDM College of Medical Sciences and Hospital; Dr. Pavitra Batakurki is Consultant in Department of OBGYN at Ashirwada Hospital.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sunil Kumar, K.S., Shyam, S. & Batakurki, P. Carboprost Versus Oxytocin for Active Management of Third Stage of Labor: A Prospective Randomized Control Study. J Obstet Gynecol India 66 (Suppl 1), 229–234 (2016). https://doi.org/10.1007/s13224-016-0842-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-016-0842-x

Keywords

Navigation